SUMMARY This study documents for the first time light and electron microscopical changes in the retinal pigment epithelium (RPE) following treatment with high dose desferrioxamine for systemic iron overload. The changes include loss of microvilli from the apical surface, patchy depigmentation, vacuolation of the cytoplasm, swelling and calcification of mitochondria, and disorganization of the plasma membrane. In addition, Bruch's membrane overlying degenerate RPE cells appeared abnormally thickened owing to the accumulation of large amounts of mature elastic fibres, pre-elastic oxytalan, and long spacing collagen. The specificity of these changes and the mechanism of toxicity are discussed.
Desferrioxamine (diethylenetriamine penta-acetic acid), an iron chelating agent, is extensively used for the treatment of systemic iron overload, ocular siderosis, and corneal rust staining. It was first isolated in 1960' from sideramine, an iron-containing metabolite of actinomyces. Ocular toxicity of desferrioxamine came to light only recently when four patients with 13-thalassaemia major were treated with a high intravenous dose to counter the effects of transfusion-induced iron overload.2 Two patients developed night blindness and field defects which were improved on withdrawal of the drug. Recently one of the two affected patients died from heart failure, and we were able to obtain an eye to study the structural lesions of ocular toxicity. We report here the relevant histochemical, light microscopic, scanning, and transmission electron microscopic findings.
Material and methods
The deceased was a 24-year-old male who had received regular blood transfusion from the age of 6 months for the treatment of P-thalassaemia major.
He underwent splenectomy at the age of 16 years. To prevent iron overload and subsequent damage to the liver and other organs he received intramuscular desferrioxamine 500 mg daily from age 8 years. From age 19 he received his desferrioxamine by overnight subcutaneous infusion. (Fig. 2) . The visual acuity was 6/9 (right) 6/12 (left). The pattern ERG, however, was still subnormal, and there was some loss of scotopic sensitivity.
In August 1983 the patient died of severe congestive cardiac failure. The body was refrigerated and the eye was removed five hours after death. The globe was placed in 3% gluteraldehyde in cacodylate buffer (pH 7.4) after a corneal disc had been trephined out to allow rapid penetration of fixative.' Forty-eight hours later small pieces of the retina along with the attached choroid and the sclera were excised from various regions of the globe and postfixed in 1% isotonic osmium tetroxide. The retina and the choroid were dehydrated in ascending grades of ethanol and finally embedded in araldite. Ultrathin sections (50-80 nm) were stained with uranyl acetate and lead citrate, and selected areas were studied with the JEOL-JEM 100C transmission electron microscope. For scanning electron microscopy tissue was dehydrated, critical point dried, sputter coated, and examined in a Hitachi S-520 scanning electron microscope. The remaining portion of the globe was processed for routine paraffin embedding. Sections were stained with haematoxylin and eosin. Perls's stain (Prussian blue reaction) was used to demonstrate deposits of iron in ocular tissues.
Results
Microscopical examination of the whole eye sections (Figs. [3] [4] [5] [6] showed deposits of iron in the nonpigmented ciliary epithelium, the ciliary muscle, stromal cells of the choroid, the sclera, and the peripheral retina, which also showed cystoid degeneration. Only occasionally were iron deposits seen in the photoreceptor layer or in the pigment epithelium. The latter showed, however, patchy depigmentation in the equatorial as well as the posterior fundus. In places the retinal pigment epithelium (RPE) cells appeared enlarged and projected into the subretinal space, which sometimes contained detached and rounded up RPE cells containing typical melanin granules. There was no evidence of melanin deposits, however, in the sensory retina around retinal blood vessels.
Scanning electron microscopy (SEM) showed well distributed microvilli on the apical surface of the normal RPE cells. In the equatorial and the posterior regions, where by light microscopy there was evidence of patchy degeneration, with SEM the degenerating pigment epithelial cells showed retraction of villi, or even their total loss, and some of the cells appeared to have large holes (Figs. 7, 8 ).
Transmission electron microscopy (Figs. 9, 10, 11) . The most important changes were observed in the retinal pigment epithelial cells, which showed a variety of structural alterations. Some of the cells had ragged borders, and the basal infolding of plasma membrane had disappeared. The cytoplasm had several alveoli, mitochondria were swollen, and some showed evidence of calcification. The retraction of cytoplasmic extensions produced apparent gaps between cells. Bruch's membrane under the degenerate or depigmented epithelial cells was abnormally thickened and showed the presence of mature elastic tissue, pre-elastic oxytalan fibres, and long-spacing bundles. However, the photoreceptors were normal and did not show any obvious abnormality in either the mitochondria or other organelles. Whether or not the changes observed in the RPE cells and in Bruch's membrane were in part due to ocular siderosis is difficult to determine, but we believe that their main cause was a toxic effect of the drug desferrioxamine. We take this view firstly because there was clinical recovery of the RPE after treatment with the drug was stopped, whereas withdrawal of desferrioxamine would have been most unlikely to be followed by an improvement had ocular siderosis been the main cause of visual failure. Secondly, systemic iron overload in experimental animals (unpublished observation) fails to produce electrophysiological changes in the retina, suggesting that such overload does not lead to ocular siderosis. Thirdly, in support of the latter observation there was no evidence of iron deposition in the degenerate RPE cells of the present case. Clinically, therefore, ocular siderosis differs from desferrioxamine toxicity in that, while in the former it is administration of the drug which brings about improvement in vision, in the latter it is its withdrawal.
The mechanism of pigment epithelial damage in this case is not clear. Since desferrioxamine chelates not only iron but also copper, zinc, cobalt, and nickel, it is possible that the visual changes were due to the removal of trace elements from the retina. It is known that urinary excretion of copper and zinc is increased during desferrioxamine infusion. Since copper metabolism appears to be defective in some cases of retinitis pigmentosa," 12 it is possible that the retinal changes in this case were also due to altered levels of copper leading to inadequacy of copperdependent intracellular oxidative processes.
Low levels of copper in Menkes's disease are associated with an abnormal ERG and VER, defective melanin formation in the RPE, and absence of elastic tissue in Bruch's membrane. Since Bruch's membrane in the present case showed the presence of both mature elastic tissue and pre-elastic oxytalan fibres, these changes cannot be explained simply on the basis of iatrogenic altered copper metabolism. '3 Whatever may be the mechanism of retinotoxicity, it would seem that, in patients with iron-overload, prolonged use of desferrioxamine in low doses is without serious ocular consequences.
Possibly the improvement in vision in the present case which followed the withdrawal of high-dose desferrioxamine was associated with limited reversal of the pathological changes. From 
